# AtaiBeckley Inc. (ATAI)

Source: https://www.quantisnow.com/company/ATAI
Generated: 2026-11-17T20:34:55.277Z

- Ticker: ATAI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2008
- SEC CIK: 0002081043
- Website: atai.life

## About

Atai Life Sciences N.V. focuses on operating as a holding company for ATAI Life Sciences AG that operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that are focused on multiple mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a GABA/nicotinic modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01 is a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder; RLS-01, a formulation of Salvinorin A for TRD; KUR-101, an oral formulation of deuterated mitragynine to treat OUD; and DMX-1001, an oral formulation of noribogaine for the treatment of OUD. The company was formerly known as Adripa Holding B.V. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.

## Latest ATAI news and filings

- 2026-09-21 13:00 UTC [SEC Form 15-12G filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-ataibeckley-inc-6721398)
- 2026-09-16 23:32 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-ataibeckley-inc-6718261)
- 2026-09-16 16:05 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-ataibeckley-inc-6717266)
- 2026-09-16 10:03 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-ataibeckley-inc-6716813)
- 2026-09-14 22:16 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-ataibeckley-inc-6715060)
- 2026-09-11 21:44 UTC [SEC Form 4] [Chief Medical Officer Craig Kevin James returned 8,437 shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax](https://www.quantisnow.com/insight/chief-medical-officer-craig-kevin-james-returned-8437-shares-to-6713375)
- 2026-09-11 21:44 UTC [SEC Form 4] [SEC Form 4 filed by Chief Operating Officer Kochendoerfer Gerd (for withholding tax)](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-operating-officer-kochendoerfer-gerd-6713374)
- 2026-09-11 21:44 UTC [SEC Form 4] [Officer Barrett Christopher Ryan Cave returned 155,066 shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding tax)](https://www.quantisnow.com/insight/officer-barrett-christopher-ryan-cave-returned-155066-shares-to-the-6713373)
- 2026-09-11 21:44 UTC [SEC Form 4] [Chief Scientific Officer Short Glenn Frank returned 42,333 shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding tax)](https://www.quantisnow.com/insight/chief-scientific-officer-short-glenn-frank-returned-42333-shares-to-6713372)
- 2026-09-11 21:44 UTC [SEC Form 4] [SEC Form 4 filed by Director Hoffman John Francis to satisfy tax liability](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-hoffman-john-francis-to-6713371)
- 2026-09-11 21:44 UTC [SEC Form 4] [SEC Form 4 filed by Chief Financial Officer Faerm Michael E. to cover taxes](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-financial-officer-faerm-michael-6713370)
- 2026-09-11 21:44 UTC [SEC Form 4] [Chief Accounting Officer Johnson Anne Nagengast returned 140,045 shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding tax)](https://www.quantisnow.com/insight/chief-accounting-officer-johnson-anne-nagengast-returned-140045-shares-to-6713369)
- 2026-09-11 21:44 UTC [SEC Form 4] [SEC Form 4 filed by Director Johnson Sabrina Martucci (withholding tax)](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-johnson-sabrina-martucci-withholding-6713368)
- 2026-09-11 21:44 UTC [SEC Form 4] [Director Angermayer Christian returned 55,756,748 shares to the company, closing all direct ownership in the company (SEC Form 4) to cover taxes](https://www.quantisnow.com/insight/director-angermayer-christian-returned-55756748-shares-to-the-company-closing-6713367)
- 2026-09-11 21:44 UTC [SEC Form 4] [SEC Form 4 filed by Director Hershberg Robert to satisfy tax liability](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-hershberg-robert-to-satisfy-6713366)
- 2026-09-11 21:44 UTC [SEC Form 4] [SEC Form 4 filed by Director Braunstein Scott (tax liability)](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-braunstein-scott-tax-liability-6713365)
- 2026-09-11 21:44 UTC [SEC Form 4] [Director Smiley Andrea Heslin returned 4,666 shares to the company, closing all direct ownership in the company (SEC Form 4) (tax liability)](https://www.quantisnow.com/insight/director-smiley-andrea-heslin-returned-4666-shares-to-the-company-6713364)
- 2026-09-11 21:44 UTC [SEC Form 4] [Officer Rao Srinivas returned 216,442 shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax](https://www.quantisnow.com/insight/officer-rao-srinivas-returned-216442-shares-to-the-company-closing-6713363)
- 2026-09-11 21:44 UTC [SEC Form 4] [SEC Form 4 filed by Director Fischer Laurent (for tax liability)](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-fischer-laurent-for-tax-6713362)
- 2026-09-11 21:44 UTC [SEC Form 4] [Director Kalali Amir H returned 4,666 shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy withholding obligation](https://www.quantisnow.com/insight/director-kalali-amir-h-returned-4666-shares-to-the-company-6713360)
- 2026-09-11 15:26 UTC [SEC Form POS AM filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-ataibeckley-inc-6712697)
- 2026-09-11 15:06 UTC [SEC Form 25-NSE filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-ataibeckley-inc-6712689)
- 2026-09-11 13:39 UTC [SEC Form POS AM filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-ataibeckley-inc-6712655)
- 2026-09-11 13:29 UTC [SEC Form POSASR filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-ataibeckley-inc-6712646)
- 2026-09-11 13:15 UTC [SEC Form 8-K] [AtaiBeckley Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year](https://www.quantisnow.com/insight/ataibeckley-inc-filed-sec-form-8-k-completion-of-acquisition-or-6712628)
- 2026-09-08 21:09 UTC [SEC Form 8-K] [AtaiBeckley Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/ataibeckley-inc-filed-sec-form-8-k-submission-of-matters-to-6708683)
- 2026-08-31 20:38 UTC [SEC Form 8-K] [AtaiBeckley Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/ataibeckley-inc-filed-sec-form-8-k-other-events-6699958)
- 2026-08-11 20:20 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ataibeckley-inc-6676005)
- 2026-08-10 10:09 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-ataibeckley-inc-6672475)
- 2026-08-05 14:25 UTC [Leadership Update] [A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout](https://www.quantisnow.com/insight/a-ceo-with-a-proven-track-record-of-success-in-6664443)
- 2026-07-30 01:46 UTC [SEC Form PREM14A filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-prem14a-filed-by-ataibeckley-inc-6654623)
- 2026-07-27 20:25 UTC [SEC Form SCHEDULE 13G filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-ataibeckley-inc-6649805)
- 2026-07-21 12:30 UTC [Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates](https://www.quantisnow.com/insight/billions-flow-into-next-generation-depression-treatments-as-pharma-innovation-accelerates-6643385)
- 2026-07-17 21:17 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-ataibeckley-inc-6641422)
- 2026-07-17 12:50 UTC [Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time](https://www.quantisnow.com/insight/big-pharma-just-paid-up-to-38-billion-for-psychedelic-6640629)
- 2026-07-16 20:01 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-ataibeckley-inc-6639595)
- 2026-07-16 20:01 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-ataibeckley-inc-6639594)
- 2026-07-16 20:01 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-ataibeckley-inc-6639591)
- 2026-07-16 20:01 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-ataibeckley-inc-6639590)
- 2026-07-16 20:01 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by AtaiBeckley Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-ataibeckley-inc-6639586)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ATAI
- Earnings history: https://www.quantisnow.com/earnings/ATAI
- Dividend history: https://www.quantisnow.com/dividends/ATAI
- Insider transactions: https://www.quantisnow.com/insiders/ATAI
- Options chain: https://www.quantisnow.com/options/ATAI
- SEC 8-K filings only: https://www.quantisnow.com/company/ATAI/8-k
- RSS and alerts for ATAI: https://www.quantisnow.com/docs/rss-feeds.md
